Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services Limited informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a suspension order for the Drug License of a store located at Nanganallur 2nd Main Road, Tamil Nadu. The order was issued by the Assistant Director, Drugs Control Administration, Chengalpattu Zone, on June 11, 2025, under Rule 65 of the Drugs and Cosmetics Act, 1940. The suspension is for five days, and the company estimates a potential revenue loss of approximately Rs 4.00 lakhs from this action.
The impact on the company is minimal, with a small potential revenue loss of about Rs 4 lakhs from a single store suspension lasting five days. This is unlikely to materially affect the company's overall operations or stock price, as it is a routine regulatory action against one outlet.